Canvas DX by Cognoa

Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral health conditions, such as autism. Canvas Dx is the company's Software as a Medical Device (SaMD) that aids physicians in diagnosing autism spectrum disorder (ASD) in young children. Canvas Dx harnesses clinically validated artificial intelligence (AI) technology to aid physicians in diagnosing ASD in children between the ages of 18 and 72 months who are at risk of developmental delay.